COMMON STOCK PURCHASE WARRANT (SERIES B)Common Stock Purchase Warrant • February 26th, 2009 • Clinical Data Inc • Laboratory analytical instruments
THIS COMMON STOCK PURCHASE WARRANT (SERIES B) (the “Warrant”) certifies that, for value received, [ ] (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time six (6) months after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the fifth (5th) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Clinical Data, Inc., a Delaware corporation (the “Company”), up to 763,825 shares (the “Warrant Shares”) of Common Stock, par value $0.01 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 26th, 2009 • Clinical Data Inc • Laboratory analytical instruments
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof among the Company and the Purchasers (the “Purchase Agreement”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 26th, 2009 • Clinical Data Inc • Laboratory analytical instruments • Delaware
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 25, 2009, by and among Clinical Data, Inc., a Delaware corporation, with headquarters located at One Gateway Center, Suite 551, Newton, Massachusetts 02458 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
